IRADIMED CORP (IRMD) › Cost of RevenueIRADIMED CORP (IRMD) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2013: $2.85M2014: $3.40M2015: $5.84M2016: $6.15M2017: $5.57M2018: $7.21M2019: $8.82M2020: $8.14M2021: $9.76M2022: $12.02M2023: $15.40M2024: $16.89M2025: $19.49M$19.49M2013Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$19.49M+15.4%2024$16.89M+9.7%2023$15.40M+28.1%2022$12.02M+23.1%2021$9.76M+19.9%2020$8.14M-7.6%2019$8.82M+22.2%2018$7.21M+29.5%2017$5.57M-9.5%2016$6.15M+5.4%2015$5.84M+71.6%2014$3.40M+19.3%2013$2.85M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share